Last 48 quarters of trend data · Healthcare · Medical - Distribution
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Cardinal Health, Inc.'s quarterly P/E stands at 31.3x, up 90.6% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 80.8% YoY to 18.1x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 34.38 | 31.26 | 26.08 | 20.87 | 42.00 | 16.40 | 17.92 | 16.25 | 25.60 | 26.14 | 16.80 | 1085.25 | — |
| — | +90.6% | +45.5% | +28.4% | +64.0% | -37.3% | +6.7% | -98.5% | — | +85.6% | — | +2504.1% | — | |
| P/S Ratio | 0.23 | 0.20 | 0.19 | 0.15 | 0.17 | 0.15 | 0.13 | 0.13 | 0.10 | 0.12 | 0.11 | 0.10 | 0.11 |
| — | +35.3% | +43.1% | +13.1% | +66.1% | +21.1% | +20.5% | +30.4% | -10.2% | +29.5% | +10.7% | +8.2% | +47.3% | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 28.21 | 7.43 | 21.94 | 10.84 | 7.78 | 2.97 | — | — | 3.20 | — | 5.82 | 12.45 | 9.37 |
| — | +150.0% | — | — | +143.5% | — | — | — | -65.9% | — | -40.6% | — | +637.3% | |
| EV / EBITDA | 18.81 | 18.11 | 15.76 | 11.64 | 17.97 | 10.02 | 10.98 | 9.79 | 10.34 | 13.53 | 9.16 | 40.23 | 19.69 |
| — | +80.8% | +43.5% | +18.9% | +73.8% | -25.9% | +19.8% | -75.7% | -47.5% | +99.9% | -91.4% | +148.1% | +13.1% | |
| EV / EBIT | 25.34 | 26.94 | 25.35 | 15.47 | 25.00 | 12.70 | 14.90 | 12.82 | 15.67 | 19.97 | 12.10 | — | 45.30 |
| — | +112.0% | +70.1% | +20.7% | +59.5% | -36.4% | +23.1% | — | -65.4% | +125.9% | — | — | -92.7% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Cardinal Health, Inc.'s operating margin was 0.8% in Q3 2026, down 0.2 pp QoQ and down 0.5 pp YoY. Gross margin expanded 6.0% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.7% | 4.1% | 3.4% | 3.6% | 3.7% | 3.9% | 3.5% | 3.6% | 3.1% | 3.5% | 3.2% | 3.2% | 3.4% |
| — | +6.0% | -3.8% | -0.4% | +17.9% | +9.7% | +9.3% | +14.1% | -9.2% | -0.3% | -0.5% | -2.0% | +0.3% | |
| Operating Margin | 1.0% | 0.8% | 1.1% | 1.0% | 0.7% | 1.3% | 1.0% | 1.1% | 0.7% | 0.7% | 0.9% | -0.1% | 0.3% |
| — | -37.2% | +8.8% | -3.9% | +4.1% | +97.8% | +13.0% | +1954.1% | +166.6% | -40.6% | +480.2% | -121.2% | +235.5% | |
| Net Margin | 0.7% | 0.7% | 0.7% | 0.7% | 0.4% | 0.9% | 0.7% | 0.8% | 0.4% | 0.5% | 0.6% | -0.0% | -0.1% |
| — | -29.0% | -0.6% | -11.7% | +0.5% | +93.8% | +13.0% | +3717.3% | +430.2% | -30.4% | +353.6% | -109.9% | -140.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | 3.2% | 0.7% | 0.8% | 0.8% | 0.5% | 1.0% | 0.9% | 0.9% | 0.5% | 0.6% | 0.8% | -0.0% | -0.1% |
| — | -33.4% | -6.4% | -12.0% | -10.5% | +85.0% | +9.0% | +3518.5% | +451.4% | -28.1% | +375.5% | -110.9% | -146.0% | |
| ROIC | 3378.7% | 13.0% | 20.2% | 22.0% | 12.1% | 32.9% | 47.1% | — | — | — | — | — | — |
| — | -60.4% | -57.1% | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Cardinal Health, Inc.'s Debt/EBITDA ratio is 11.8x, up from 10.4x last quarter — elevated, raising questions about debt serviceability.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | 3.05 | 11.78 | 10.35 | 10.02 | 14.67 | 8.20 | 10.26 | 6.89 | 9.44 | 10.72 | 6.95 | 33.41 | 15.02 |
| — | +43.7% | +0.9% | +45.6% | +55.4% | -23.6% | +47.8% | -79.4% | -37.1% | +69.2% | -93.3% | +95.4% | -39.2% | |
| Current Ratio | 0.94 | 0.91 | 0.91 | 0.96 | 0.94 | 0.94 | 1.02 | 0.95 | 0.98 | 0.98 | 0.98 | 0.99 | 1.00 |
| — | -3.9% | -10.8% | +0.9% | -4.5% | -4.1% | +3.2% | -4.1% | -2.1% | -4.5% | -5.6% | -4.5% | -7.2% | |
| Quick Ratio | 0.50 | 0.48 | 0.44 | 0.52 | 0.50 | 0.50 | 0.54 | 0.50 | 0.56 | 0.51 | 0.50 | 0.50 | 0.52 |
| — | -5.0% | -17.5% | +4.5% | -10.1% | -1.1% | +6.7% | -1.3% | +7.1% | -2.1% | -3.9% | -5.2% | -7.8% | |
| Interest Coverage | 10.77 | 5.04 | 6.16 | 8.47 | 6.19 | 9.99 | 15.60 | 17.91 | 98.00 | 13.21 | 171.67 | -3.00 | 9.07 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Deep dive into CAH consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CAH stock.
Cardinal Health, Inc.'s current P/E is 34.4x. The average P/E over the last 4 quarters is 30.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cardinal Health, Inc.'s current operating margin is 1.0%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cardinal Health, Inc.'s business trajectory between earnings reports.